QualityStocksNewsBreaks – Announces Leadership Overhaul and Strategic Merger in Addiction Therapeutics
Branded Legacy (OTC: BLEG), a diversified holdings firm, announced a full leadership transition and a pending merger aimed at entering the addiction therapeutics space. Interim CEO Jeffery Robison now leads the company following the resignation of the entire prior management team. A Letter of Intent has been submitted for a merger with a company specializing in advanced intranasal drug delivery, including a patented all-in-one naloxone device. The combined entity projects $40 million in first-year revenue and aims to disrupt the opioid overdose and broader addiction treatment markets with scalable, cost-effective solutions. Merger closing is expected within two weeks, pending approvals. To…
